With 72504.0 shares changed hands, the volume of the stock remained lighter than its average volume of 90060.0 shares. During the session, the Semiconductors company that operates in wider Technology sector, reached to the highest price of $6.1 whereas the lowest price it dropped to was $5.96. The 52-week range on MRAM shows that it touched its highest point at $7.00 and its lowest point at $4.34 during that stretch. It currently has a 1-year price target of $8.50. Beta for the stock currently stands at 0.17.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MRAM was up-trending over the past week, with a rise of 0.50%, but this was up by 0.33% over a month. Three-month performance surged to 13.25% while six-month performance fell -8.72%. The stock gained 1.17% in the past year, while it has lost -5.01% so far this year. A look at the trailing 12-month EPS for MRAM yields -0.01 with Next year EPS estimates of 0.14. For the next quarter, that number is -0.04. This implies an EPS growth rate of -287.50% for this year and 286.67% for next year.
Float and Shares Shorts:
At present, 22.35 million MRAM shares are outstanding with a float of 16.97 million shares on hand for trading. On 2025-05-30, short shares totaled 0.7 million, which was 313.00000000000006 higher than short shares on 1745971200. In addition to Dr. Sanjeev Aggarwal Ph.D. as the firm’s President, CEO & Director, Mr. David Schrenk serves as its Vice President of Sales & Business Development.
Institutional Ownership:
Through their ownership of 0.64715 of MRAM’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, MRAM reported revenue of $13138000.0 and operating income of -$1932000.0. The EBITDA in the recently reported quarter was -$1086000.0 and diluted EPS was -$0.05.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MRAM since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With MRAM analysts setting a high price target of 9.0 and a low target of 8.0, the average target price over the next 12 months is 8.5. Based on these targets, MRAM could surge 48.27% to reach the target high and rise by 31.8% to reach the target low. Reaching the average price target will result in a growth of 40.03% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.21267 being high and -$0.22733 being low. For MRAM, this leads to a yearly average estimate of -$0.22.
